06/04/2026
Clinical evidence* showed that Flamigel® RT reduced the incidence of moist desquamation by 80% versus standard care in radiotherapy patients.
A clear difference that highlights the value of recommending Flamigel® RT from day one, to help protect skin throughout treatment.
*Censabella S et al., Efficacy of a hydroactive colloid gel versus historical controls for the prevention of radiotherapy induced moist desquamation in breast cancer patients. Eur J Oncol Nurs. 2017;29:1-7.
Flamigel® RT is a hydro-active colloid gel for the symptomatic treatment of low grade radiotherapy-induced skin reactions.